Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a non-randomized, clinical phase I trial studying SER-155 in patients with Diarrhea (Immune checkpoint inhibitors (ICIs) induced)
Treatment-related adverse events
No published results were found as of May 2026
…